×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Van Naarden Jacob

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LLYELI LILLY & CoVan Naarden JacobEVP & Pres., Loxo@LillyFeb 12, 2024Option Exercise$737.262,3691,746,56916,147Feb 14, 2024, 04:41 PM
LLYELI LILLY & CoVan Naarden JacobEVP & Pres., Loxo@LillyFeb 01, 2024Option Exercise$645.611,6851,087,85313,778Feb 02, 2024, 04:22 PM
LLYELI LILLY & CoVan Naarden JacobEVP and CEO Loxo@LillyFeb 16, 2023Option Exercise$335.011,314440,20311,845Feb 21, 2023, 04:35 PM
LLYELI LILLY & CoVan Naarden JacobEVP and CEO Loxo@LillyFeb 10, 2023Option Exercise$345.122,407830,70410,374Feb 14, 2023, 05:07 PM
LLYELI LILLY & CoVan Naarden JacobSVP, CEO LoxoONC, Pres LlyONCFeb 16, 2022Option Exercise$243.842,186533,0347,967Feb 17, 2022, 04:44 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Operating OfficerFeb 15, 2019Option Exercise$235.0019,0004,465,0000Feb 15, 2019, 09:18 AM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Operating OfficerJul 09, 2018Option Exercise$3.651,5415,62213,541Jan 17, 2019, 08:08 AM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 10, 2018Option Exercise$13.674,50061,51518,200Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 10, 2018Sale$133.654,500601,43417,800Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 11, 2018Option Exercise$7.5711,50087,05120,700Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 11, 2018Sale$137.354,500618,08017,800Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2018Sale$141.664,500637,48117,251Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 26, 2018Option Exercise$3.655,50020,06419,200Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 26, 2018Sale$153.135,500842,22417,644Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2018Option Exercise$8.234,50037,03118,200Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 03, 2018Sale$167.165,500919,37617,200Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 04, 2018Option Exercise$3.654,50016,41618,200Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 04, 2018Sale$162.644,500731,88417,600Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 03, 2018Option Exercise$3.655,50020,06419,200Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 12, 2018Option Exercise$3.655,50020,06419,200Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 12, 2018Sale$166.605,500916,27718,444Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 13, 2018Option Exercise$3.654,50016,41618,200Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 13, 2018Sale$165.984,500746,90315,500Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 13, 2018Option Exercise$3.655,50020,06419,200Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 13, 2018Sale$158.875,500873,80418,470Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2018Option Exercise$3.654,50016,41618,200Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2018Sale$159.924,500719,64217,600Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 10, 2018Sale$179.691,541276,90714,561Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 09, 2018Option Exercise$3.651,5415,62215,241Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 09, 2018Sale$187.301,541288,63114,941Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 10, 2018Option Exercise$3.651,5415,62215,241Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 20, 2018Option Exercise$3.6513,54149,39813,541Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 20, 2018Sale$179.341,541276,37012,400Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 19, 2018Option Exercise$3.651,5415,6221,541Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 19, 2018Sale$176.941,541272,665676Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 14, 2018Sale$137.541,541211,9491,300May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 15, 2018Option Exercise$3.651,5415,6221,541May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 15, 2018Sale$137.291,541211,5661,341May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 14, 2018Option Exercise$3.651,5415,6221,541May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 24, 2018Option Exercise$3.651,5415,6221,541Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 24, 2018Sale$131.671,541202,8981,300Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 25, 2018Option Exercise$3.651,5415,6221,541Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 25, 2018Sale$130.801,541201,5631,241Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 14, 2018Sale$131.461,541202,580646Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 13, 2018Option Exercise$3.651,5415,6221,541Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 13, 2018Sale$131.351,541202,4151,441Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 14, 2018Option Exercise$3.651,5415,6221,541Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 13, 2018Option Exercise$3.651,5415,6221,541Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 13, 2018Sale$99.241,541152,9351,241Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 12, 2018Option Exercise$3.651,5415,6221,541Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 12, 2018Sale$93.431,541143,9781,041Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 16, 2018Sale$88.131,541135,802900Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 17, 2018Option Exercise$3.651,5415,6221,541Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 17, 2018Sale$88.301,541136,0651,095Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 16, 2018Option Exercise$3.651,5415,6221,541Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 14, 2017Option Exercise$3.651,5415,6221,541Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 14, 2017Sale$83.271,541128,319700Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 15, 2017Option Exercise$3.651,5415,6221,541Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 15, 2017Sale$79.121,541121,9211,141Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 28, 2017Sale$74.161,541114,282941Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2017Option Exercise$3.651,5415,6221,541Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2017Sale$74.831,541115,316700Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 28, 2017Option Exercise$3.651,5415,6221,541Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 31, 2017Option Exercise$3.651,5415,6221,541Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 31, 2017Sale$86.521,541133,321400Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 30, 2017Option Exercise$3.651,5415,6221,541Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 30, 2017Sale$87.261,541134,468441Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 18, 2017Sale$89.201,541137,4621,185Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 19, 2017Option Exercise$3.651,5415,6221,541Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 19, 2017Sale$88.791,541136,8271,044Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 18, 2017Option Exercise$3.651,5415,6221,541Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2017Option Exercise$3.651,5415,6221,541Aug 16, 2017, 05:22 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2017Sale$73.731,541113,619541Aug 16, 2017, 05:22 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 15, 2017Option Exercise$3.651,5415,6221,541Aug 16, 2017, 05:22 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 15, 2017Sale$73.421,541113,1340Aug 16, 2017, 05:22 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe